Literature DB >> 2386136

Preeclampsia in diabetic pregnancies.

P R Garner1, M E D'Alton, D K Dudley, P Huard, M Hardie.   

Abstract

Diabetic pregnancies complicated by preeclampsia are of concern because of poor perinatal outcome. However, with improved maternal and fetal surveillance the impact of preeclampsia in diabetic pregnancies is declining. This prospective controlled study compared the incidence of preeclampsia and maternal-fetal outcome in 334 diabetic pregnancies and 16,534 nondiabetic pregnancies. The incidence of preeclampsia was 9.9% (33/334) in diabetic pregnancies compared with 4.3% (716/16,534) in nondiabetic controls. The incidence of preeclampsia rose with increasing severity of diabetes by White classification, but was still 8.9% after exclusion of diabetic patients with nephropathy or chronic hypertension. The perinatal mortality rate per 1000 births was 60 for preeclamptic diabetic patients compared with 3.3 for normotensive diabetic patients. Parity, maternal age, and blood glucose control were similar in preeclamptic diabetic patients compared with normotensive diabetic patients. We conclude that preeclampsia is twice as common in diabetic pregnancies compared with normal controls.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2386136     DOI: 10.1016/0002-9378(90)91184-e

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  26 in total

1.  Placensin is a glucogenic hormone secreted by human placenta.

Authors:  Yiping Yu; Jia-Huan He; Lin-Li Hu; Lin-Lin Jiang; Lanlan Fang; Gui-Dong Yao; Si-Jia Wang; Qingling Yang; Yanjie Guo; Lin Liu; Trisha Shang; Yorino Sato; Kazuhiro Kawamura; Aaron Jw Hsueh; Ying-Pu Sun
Journal:  EMBO Rep       Date:  2020-04-24       Impact factor: 8.807

Review 2.  Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies.

Authors:  Kirsten Duckitt; Deborah Harrington
Journal:  BMJ       Date:  2005-03-02

Review 3.  Hypertension and the pregnancy complicated by diabetes.

Authors:  Gustavo F Leguizamón; Natalia P Zeff; Alberto Fernández
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

Review 4.  Management of diabetic pregnancy.

Authors:  M D Littley
Journal:  Postgrad Med J       Date:  1994-09       Impact factor: 2.401

5.  Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study.

Authors:  Piya Chaemsaithong; Roberto Romero; Adi L Tarca; Steven J Korzeniewski; Alyse G Schwartz; Jezid Miranda; Ahmed I Ahmed; Zhong Dong; Sonia S Hassan; Lami Yeo; Tinnakorn Tinnakorn
Journal:  J Matern Fetal Neonatal Med       Date:  2014-09-29

Review 6.  Oxidative stress in the placenta.

Authors:  Leslie Myatt; Xiaolan Cui
Journal:  Histochem Cell Biol       Date:  2004-07-10       Impact factor: 4.304

7.  Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial.

Authors:  David R McCance; Valerie A Holmes; Michael J A Maresh; Christopher C Patterson; James D Walker; Donald W M Pearson; Ian S Young
Journal:  Lancet       Date:  2010-06-26       Impact factor: 79.321

8.  Retinol binding protein 4--a novel association with early-onset preeclampsia.

Authors:  Edi Vaisbuch; Roberto Romero; Shali Mazaki-Tovi; Offer Erez; Sun Kwon Kim; Tinnakorn Chaiworapongsa; Francesca Gotsch; Nandor Gabor Than; Zhong Dong; Percy Pacora; Ronald Lamont; Lami Yeo; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Perinat Med       Date:  2010-03       Impact factor: 1.901

9.  Influence of maternal insulin-dependent diabetes mellitus on neonatal morbidity.

Authors:  D J Hunter; R F Burrows; P T Mohide; R K Whyte
Journal:  CMAJ       Date:  1993-07-01       Impact factor: 8.262

10.  Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus.

Authors:  Meryam Sugulle; Ralf Dechend; Florian Herse; M Susanne Weedon-Fekjaer; Guro M Johnsen; K Bridget Brosnihan; Lauren Anton; Friedrich C Luft; Kai C Wollert; Tibor Kempf; Anne Cathrine Staff
Journal:  Hypertension       Date:  2009-05-26       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.